Advance Capital I’s Pfizer PFE Stock Holding History

Advance Capital I’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-48,800	Closed	-$1.37M	–	187
2016 Q1	$1.37M	Buy	48,800 +12,121	+33%	+$346K	1.42%	21
2015 Q4	$1.12M	Sell	36,679 -1,792	-5%	-$56.4K	1.07%	37
2015 Q3	$1.15M	Buy	38,471 +18,972	+97%	+$608K	0.94%	31
2015 Q2	$620K	Buy	+19,499	New	+$636K	0.41%	132
2014 Q1	–	Sell	-29,723	Closed	-$864K	–	250
2013 Q4	$864K	Hold	29,723	–	–	0.41%	67
2013 Q3	$810K	Buy	29,723 +7,062	+31%	+$192K	0.41%	61
2013 Q2	$602K	Buy	+22,661	New	+$626K	0.3%	129

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Advance Capital I's PFE Position: Q2 2016 in Review

Advance Capital I sold out of Pfizer (PFE) in Q2 2016, closing a stake of 48,800 shares — an estimated $1.37M sold.

Advance Capital I first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $1.37M in Q1 2016. 1,992 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Advance Capital I reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
Advance Capital I sold 48,800 Pfizer shares in Q2 2016, an estimated $1.37M.
Advance Capital I first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
Advance Capital I's Pfizer position peaked at $1.37M in Q1 2016.
1,992 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Advance Capital I's 13F filing for Q2 2016, filed 9 Aug 2016.